These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21226573)

  • 1. The age-old struggle against the antivaccinationists.
    Poland GA; Jacobson RM
    N Engl J Med; 2011 Jan; 364(2):97-9. PubMed ID: 21226573
    [No Abstract]   [Full Text] [Related]  

  • 2. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinating Children against Covid-19 - The Lessons of Measles.
    Klass P; Ratner AJ
    N Engl J Med; 2021 Feb; 384(7):589-591. PubMed ID: 33471977
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].
    Rotily M; Guagliardo V; Fontaine D; Garros B; Mayer C; Arrighi J; Woronoff AS; Ledesert B; Lepec R; Chabaud F; Janvrin MP; Baudier F
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):331-41. PubMed ID: 11567200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative merits of the single and triple MMR vaccines.
    Unstead-Joss L
    J R Soc Promot Health; 2005 Jul; 125(4):155; author reply 155. PubMed ID: 16094921
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
    Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
    Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
    Lum LC; Borja-Tabora CF; Breiman RF; Vesikari T; Sablan BP; Chay OM; Tantracheewathorn T; Schmitt HJ; Lau YL; Bowonkiratikachorn P; Tam JS; Lee BW; Tan KK; Pejcz J; Cha S; Gutierrez-Brito M; Kaltenis P; Vertruyen A; Czajka H; Bojarskas J; Brooks WA; Cheng SM; Rappaport R; Baker S; Gruber WC; Forrest BD
    Vaccine; 2010 Feb; 28(6):1566-74. PubMed ID: 20003918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From the struggle for freedom to the denial of evidence: history of the anti-vaccination movements in Europe].
    Tafuri S; Martinelli D; Prato R; Germinario C
    Ann Ig; 2011; 23(2):93-9. PubMed ID: 21770225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The failure to respect parents' concerns could be damaging.
    O'Hara L
    Nurs Stand; 2010 Mar 17-23; 24(28):26. PubMed ID: 20391672
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases.
    Omer SB; Salmon DA; Orenstein WA; deHart MP; Halsey N
    N Engl J Med; 2009 May; 360(19):1981-8. PubMed ID: 19420367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking in time: does health policy need history as evidence?
    Berridge V
    Lancet; 2010 Mar; 375(9717):798-9. PubMed ID: 20217913
    [No Abstract]   [Full Text] [Related]  

  • 15. Parents' reported reasons for avoiding MMR vaccination. A telephone survey.
    Dannetun E; Tegnell A; Hermansson G; Giesecke J
    Scand J Prim Health Care; 2005 Sep; 23(3):149-53. PubMed ID: 16162466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination and autoimmune diseases: the argument against.
    Rubinstein E
    Isr Med Assoc J; 2004 Jul; 6(7):433-5. PubMed ID: 15274538
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral vaccines in historical perspective.
    Hilleman MR
    Dev Biol Stand; 1995; 84():107-16. PubMed ID: 7796942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.